{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:21:46Z","timestamp":1792419706006,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.hlc.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T21:23:19Z","timestamp":1607548999000},"page":"786-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications"],"prefix":"10.1016","volume":"30","author":[{"given":"Filippos","family":"Triposkiadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-3946","authenticated-orcid":false,"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisios","family":"Boudoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.hlc.2020.11.008_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"7821","key":"10.1016\/j.hlc.2020.11.008_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.hlc.2020.11.008_bib3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/ppul.24885","article-title":"Clinical manifestations of children with COVID-19: a systematic review","volume":"55","author":"de Souza","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.hlc.2020.11.008_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"10.1016\/j.hlc.2020.11.008_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.hlc.2020.11.008_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.hlc.2020.11.008_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.21037\/atm.2020.03.61","article-title":"A\u00a0profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection","volume":"8","author":"Dai","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.21037\/atm.2017.03.36","article-title":"The expression of proline-specific enzymes in the human lung","volume":"5","author":"Vliegen","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fendo.2013.00166","article-title":"New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms","volume":"4","author":"Zhuo","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.hlc.2020.11.008_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/heartjnl-2017-312121","article-title":"Heartbeat: renin-angiotensin system blockade for prevention of cardiovascular disease","volume":"103","author":"Otto","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2020.11.008_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hlc.2020.11.008_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1527-3466.2007.00012.x","article-title":"Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments","volume":"25","author":"Trask","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.hlc.2020.11.008_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.hlc.2020.11.008_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hlc.2020.11.008_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2020.11.008_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2015.00387","article-title":"The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis","volume":"6","author":"Waumans","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.hlc.2020.11.008_bib17","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1111\/j.1742-4658.2008.06587.x","article-title":"Characterization of membrane-bound prolyl endopeptidase from brain","volume":"275","author":"Tenorio-Laranga","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.hlc.2020.11.008_bib18","doi-asserted-by":"crossref","first-page":"180017","DOI":"10.1183\/16000617.0017-2018","article-title":"The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease","volume":"27","author":"Patel","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.hlc.2020.11.008_bib19","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.180.8.5662","article-title":"A\u00a0novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation","volume":"180","author":"Gaggar","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.hlc.2020.11.008_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-10-38","article-title":"N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD","volume":"10","author":"O'Reilly","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib21","doi-asserted-by":"crossref","first-page":"L255","DOI":"10.1152\/ajplung.00304.2010","article-title":"Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown","volume":"300","author":"Braber","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2020.11.008_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1165\/rcmb.2015-0108OC","article-title":"Toll-like receptor 4 engagement mediates prolyl endopeptidase release from airway epithelia via exosomes","volume":"54","author":"Szul","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hlc.2020.11.008_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","article-title":"Neutrophils contain prolyl endopeptidase and generate the\u00a0chemotactic peptide, PGP, from collagen","volume":"217","author":"O'Reilly","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.hlc.2020.11.008_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/187152711794653742","article-title":"Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research","volume":"10","author":"Penttinen","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.hlc.2020.11.008_bib25","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hlc.2020.11.008_bib26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.118.10918","article-title":"The meaning of Mas","volume":"72","author":"Bader","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2020.11.008_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.hlc.2020.11.008_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu","year":"2020","journal-title":"J\u00a0Transl Int Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib30","first-page":"841","article-title":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)","volume":"9","author":"Brake","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.hlc.2020.11.008_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157340811795713756","article-title":"Ectodomain shedding of ACE and ACE2 as regulators of their protrin functions","volume":"7","author":"Iwata","year":"2011","journal-title":"Curr Enzym Inhib"},{"key":"10.1016\/j.hlc.2020.11.008_bib32","first-page":"91","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J\u00a0Adv Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.2067","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","volume":"210","author":"He","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.hlc.2020.11.008_bib34","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.jaut.2020.102463","article-title":"Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19","volume":"112","author":"Li","year":"2020","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.hlc.2020.11.008_bib35","first-page":"607","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.hlc.2020.11.008_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12969-016-0130-4","article-title":"Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome","volume":"15","author":"Bracaglia","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.hlc.2020.11.008_bib37","doi-asserted-by":"crossref","first-page":"m2512","DOI":"10.1136\/bmj.m2512","article-title":"Covid-19: demand for dexamethasone surges as RECOVERY trial publishes preprint","volume":"369","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2020.11.008_bib38","doi-asserted-by":"crossref","first-page":"e2013136","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2020.11.008_bib39","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hlc.2020.11.008_bib40","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201ccytokine storm\u201d relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hlc.2020.11.008_bib42","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/HYPERTENSIONAHA.114.03871","article-title":"Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension","volume":"64","author":"Shenoy","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2020.11.008_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2013.04.017","article-title":"Diminazene aceturate improves autonomic modulation in pulmonary hypertension","volume":"713","author":"Rigatto","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hlc.2020.11.008_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-012-0859-2","article-title":"Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury","volume":"90","author":"Rey-Parra","year":"2012","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.hlc.2020.11.008_bib46","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.burns.2015.04.010","article-title":"Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome","volume":"41","author":"Yilin","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.hlc.2020.11.008_bib47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib49","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.hlc.2020.11.008_bib50","doi-asserted-by":"crossref","first-page":"L653","DOI":"10.1152\/ajplung.00308.2017","article-title":"The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome","volume":"315","author":"Sharma","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2020.11.008_bib51","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1096\/fj.07-096230","article-title":"Induction of lung emphysema is prevented by L-arginine-threonine-arginine","volume":"22","author":"van Houwelingen","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.hlc.2020.11.008_bib52","doi-asserted-by":"crossref","first-page":"2476824","DOI":"10.1155\/2018\/2476824","article-title":"Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome","volume":"2018","author":"Patel","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hlc.2020.11.008_bib53","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/molecules17033586","article-title":"Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice","volume":"17","author":"Chu","year":"2012","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.hlc.2020.11.008_bib54","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s10753-020-01264-3","article-title":"The antioxidant rosmarinic acid ameliorates oxidative lung damage in experimental allergic asthma via modulation of NADPH oxidases and antioxidant enzymes","volume":"43","author":"Liang","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.hlc.2020.11.008_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aller.2018.04.004","article-title":"Rosmarinic acid affects immunological and inflammatory mediator levels and restores lung pathological features in asthmatic rats","volume":"47","author":"Shakeri","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.hlc.2020.11.008_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharep.2017.08.010","article-title":"Prophylactic effect of rosmarinic acid on tracheal responsiveness, white blood cell count and oxidative stress markers in lung lavage of sensitized rats","volume":"70","author":"Eftekhar","year":"2018","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.hlc.2020.11.008_bib57","first-page":"CD002309","article-title":"Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease","volume":"5","author":"Janjua","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2020.11.008_bib58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3904\/kjim.2020.035","article-title":"Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease","volume":"35","author":"Rhee","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib59","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.hlc.2020.11.008_bib60","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1164\/rccm.201503-0543OC","article-title":"A\u00a0randomized, placebo-controlled trial of roflumilast: effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease","volume":"192","author":"Wells","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2020.11.008_bib61","doi-asserted-by":"crossref","first-page":"e0121725","DOI":"10.1371\/journal.pone.0121725","article-title":"The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation","volume":"10","author":"Konrad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2020.11.008_bib62","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.33549\/physiolres.933679","article-title":"Effects of roflumilast, a phosphodiesterase-4 inhibitor, on the lung functions in a saline lavage-induced model of acute lung injury","volume":"66","author":"Kosutova","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jss.2019.03.028","article-title":"Phosphodiesterase-4 inhibitor roflumilast attenuates pulmonary air emboli-induced lung injury","volume":"241","author":"Peng","year":"2019","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.hlc.2020.11.008_bib64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.dsx.2020.05.022","article-title":"Angiotensin converting enzyme-2 as therapeutic target in COVID-19","volume":"14","author":"Roshanravan","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.hlc.2020.11.008_bib65","doi-asserted-by":"crossref","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","volume":"9","author":"Guo","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2020.11.008_bib66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.hlc.2020.11.008_bib67","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2020.11.008_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.hlc.2020.11.008_bib69","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.hlc.2020.11.008_bib70","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.hlc.2020.11.008_bib71","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.110.164244","article-title":"Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2","volume":"57","author":"Zhong","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2020.11.008_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.peptides.2016.03.008","article-title":"Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR\/ERK signaling in apolipoprotein E-deficient mice","volume":"79","author":"Chen","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.hlc.2020.11.008_bib73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A\u00a0pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2020.11.008_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2020.11.008_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kint.2018.01.029","article-title":"Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation","volume":"94","author":"Liu","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.hlc.2020.11.008_bib76","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.hlc.2020.11.008_bib77","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2020 REPORT."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620315389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620315389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:04:02Z","timestamp":1761415442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950620315389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1443950620315389"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2020.11.008","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}